No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2286 |
4. Check minimum number of eventsNone |
2286 |
5. Include endpointsNone |
2286 |
6. Filter based on genotype QC (FinnGen only) |
2227 |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Nonspecific lymphadenitis based on the number of shared cases.
Similar with more cases:
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 21458 | 12186 | 9189 |
Only index persons | 19301 | 11160 | 8141 |
Unadjusted period prevalence (%) | |||
Whole population | 0.31 | 0.35 | 0.26 |
Only index persons | 0.37 | 0.41 | 0.31 |
Median age at first event (years) | |||
Whole population | 18.15 | 19.68 | 16.00 |
Only index persons | 17.89 | 19.42 | 15.79 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2227 | 1485 | 742 |
Unadjusted period prevalence (%) | 0.51 | 0.58 | 0.37 |
Median age at first event (years) | 19.77 | 19.67 | 19.96 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint I9_LYMPHADE and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
I9_LYMPHADE | 1.61 [1.34, 1.93] | < 0.001 |
Birth year | 0.998 [0.99, 1.01] | 0.571 |
During the follow-up period (1.1.1998 — 31.12.2019), 257 out of 3491 females with I9_LYMPHADE died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
I9_LYMPHADE | 1.931 [1.62, 2.3] | < 0.001 |
Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 298 out of 3230 males with I9_LYMPHADE died.
Mortality risk
Mortality risk for people of age
years, who have I9_LYMPHADE.N-year risk | Females | Males |
---|---|---|
1 | 0.154% | 0.251% |
5 | 0.839% | 1.932% |
10 | 2.414% | 5.144% |
15 | 4.555% | 10.168% |
20 | 8.072% | 16.551% |
Relationships between endpoints
↥Index endpoint: I9_LYMPHADE – Nonspecific lymphadenitis
GWS hits: 1